Evaluating Drug–Drug Interactions in Cancer Patients Receiving Anticoagulants and Antineoplastics
Despoina Pantazi, Teaching Staff at the Department of Chemistry, University of Ioannina, shared a post on LinkedIn:
“Take a look at my new article!
“Evaluating DDIs in cancer patients receiving anticoagulants and antineoplastics: a scoping review focusing on therapeutic efcacy and safety”
Medical Oncology (2025) 42:511
Many thanks to all participants in this work:
The oncologists:
Dr Melina Gerolatsite, Nanteznta Torounidou, Prof Davide Mauri, and Dr Nikos Tsoukalas
The hematologists:
Prof Grigoris Gerotziafas and Prof Elmina Lefkou
The cardiologist:
Costas Pappas, University Hospital of Ioannina
And
Emeritus professor Alexandros Tselepis for his comments.”
Title: Evaluating DDIs in cancer patients receiving anticoagulants and antineoplastics: a scoping review focusing on therapeutic efficacy and safety
Authors: Melina Yerolatsite, Nikolaos Tsoukalas, Grigoris Gerotziafas, Costas Pappas, Nanteznta Torounidou, Eleftheria Lefkou, Davide Mauri, Alexandros D. Tselepis, Despoina Pantazi
Read full article here.
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia